Drug intelligence / Profile preview

siRNA against Fkbp5

Development stage
Preclinical
Modality
Chemically Modified siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Conjugated siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Intrathecal
01

Overview

siRNA against Fkbp5 is a small interfering RNA designed to silence the expression of the FK506-binding protein 5 (FKBP5). FKBP5 is a co-chaperone protein that regulates the sensitivity of the glucocorticoid receptor (GR) and is a key modulator of the stress response. In the context of traumatic brain injury (TBI), research indicates that Fkbp5 is hyperexpressed during peak microglial activation. Experimental studies in murine models have shown that specific knockdown of Fkbp5 in microglia using siRNA can partially reverse the inflammatory phenotype and mitigate long-term epigenetic scars and behavioral deficits, such as anxiety and social interaction disorders, associated with neonatal TBI.

Other names
Fkbp5 siRNAFkbp-5 siRNAFkbp 5 siRNAsiRNA targeting Fkbp5
02

Targets

FKBP5 (FK506-binding protein 5)

Beyond the preview

Go deeper on siRNA against Fkbp5.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on siRNA against Fkbp5.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call